A. Lee

Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.

A. Bridges, M. Towle, A. Lee, 1993, Cancer research.

Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists.

I. Aliagas, R. Webb, T. Somers, 1998, Bioorganic & medicinal chemistry.

Characterization of a Mutant HIV-1 Reverse Transcriptase Resistant to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)-imidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150)

R. Colonno, A. Patick, R. Rose, 1994 .

Aminoacetyl moiety as a potential surrogate for diacylhydrazine group of SC-51089, a potent PGE2 antagonist, and its analogs.

A. Lee, T. Hagen, A. Stapelfeld, 1996, Journal of medicinal chemistry.

The synthesis of three 4-substituted benzo[b]thiophene-2-carboxamidines as potent and selective inhibitors of urokinase.

A. Bridges, M. Towle, C. Schwartz, 1993, Bioorganic & medicinal chemistry.

From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.

B Kohl, R. Mcdowell, B. Kohl, 1997, Journal of medicinal chemistry.